Advertisement

Topics

Daiichi Pure Chemicals Company Limited Company Profile

05:49 EDT 18th June 2018 | BioPortfolio

Drug Discovery

Location

3-13-5 Nihombashi Chuo-ku
Tokyo
Tokyo
103
Japan

Contact

Fax: 81 3 3272 0671


News Articles [1526 Associated News Articles listed on BioPortfolio]

Wako Chemicals now FUJIFILM Wako Chemicals

Wako Chemicals USA, Inc., a Virginia corporation headquartered in Richmond, Virginia ("Wako Chemicals"), is pleased to announce the company's name change to "FUJIFILM Wako Chemicals U.S.A. Corporation...

Daiichi Sankyo to restructure vaccines subsidiary

Daiichi Sankyo is set to restructure its wholly-owned Kitasato Daiichi Sankyo Vaccine subsidiary into a specialised manufacturing division to enhance...Read More... The post Daiichi Sankyo to restruct...

Daiichi Sankyo Presents Phase 3 ENLIVEN Study of Pexidartinib, Demonstrating Statistically Significant Clinical Improvement Across Multiple Endpoints in Patients with Tenosynovial Giant Cell Tumor

Tokyo, Basking Ridge, NJ, and Munich – (June 4, 2018) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the phase 3 ENLIVEN study showed a statistically significan...

Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared with Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations (QuANTUM-R Study)

Tokyo, Munich, and Basking Ridge, NJ – (May 8, 2018) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announces that the pivotal QuANTUM-R phase 3 study of single agent quizartinib me...

Daiichi Sankyo doses first patient in Phase ll trial of DS-8201

Daiichi Sankyo Company has dosed the first patient in a Phase ll trial evaluating the efficacy and safety of DS-8201...Read More... The post Daiichi Sankyo doses first patient in Phase ll trial of DS-...

Daiichi Sankyo’s Quizartinib Significantly Prolongs Overall Survival in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations

TOKYO, MUNICH, and BASKING RIDGE, N.J., May 8, 2018 /PRNewswire/ — Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announces that the pivotal QuANTUM-R phase 3 study of single agent ...

Daiichi-Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer

TOKYO, BASKING RIDGE, N.J. and MUNICH, Jan. 18, 2018 /PRNewswire/ — Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated phase 1 safety and efficacy data for ...

Daiichi Sankyo to develop new inflammatory disease drugs

Daiichi Sankyo has formed a new consortium focused on research and discovery of medicines over a period of five years...Read More... The post Daiichi Sankyo to develop new inflammatory disease drugs a...

PubMed Articles [604 Associated PubMed Articles listed on BioPortfolio]

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

Harnessing the periplasm of bacteria to develop biocatalyst for biosynthesis of highly pure chemicals.

Although biocatalytic transformation has shown great promise in chemical synthesis, there remain significant challenges in controlling high selectivity without the formation of undesirable byproducts....

Galleria mellonella larvae allow the discrimination of toxic and non-toxic chemicals.

The acute toxicities of 19 chemicals were assessed using G. mellonella larvae. The results obtained were compared against LD50 values derived from in vitro cytotoxicity tests and against in vivo acu...

Assessment of medium-term cardiovascular disease risk after Japan's 2011 Fukushima Daiichi nuclear accident: a retrospective analysis.

To assess the medium-term indirect impact of the 2011 Fukushima Daiichi nuclear accident on cardiovascular disease (CVD) risks and to identify whether risk factors for CVD changed after the accident.

Interaction of toxic chemicals with microplastics: A critical review.

Occurrence of microplastics (MPs) in the environment has attracted great attention as it has become a global concern. This review aims to systematically demonstrate the role of marine microplastic as ...

Clinical Trials [440 Associated Clinical Trials listed on BioPortfolio]

Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa

The purpose of this study is to determine occurrence of pure red cell aplasia in a group of participants with chronic renal insufficiency and with resistance criteria to epoetin alfa treat...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Olmesartan Medoxomil Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Olmesartan Medoxomil Tablets 40 mg and Benicar® 40 mg Tablets of Daiichi Sankyo Inc., USA. Dosing periods of studies were ...

Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System

The aim of this study is to evaluate the potential improvement in colonoscopy procedure's outcomes when using the Pure-Vu System in hospitalized patients who are indicated for colonoscopy ...

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - D...

A Study to Observe Patients Who Have Developed a More Severe Form of Anemia (Pure Red Cell Aplasia) Which is Associated With the Erythropoietin Treatment for Their Original Anemia

The purpose of this study is to investigate a possible relationship between antibodies to recombinant erythropoietin and the clinical course of Pure Red Cell Anemia (PRCA) in patients curr...

Companies [2213 Associated Companies listed on BioPortfolio]

Daiichi Pure Chemicals Company Limited

Drug Discovery

Wako Chemicals USA, Inc

Wako Chemicals USA, Inc. is a wholly owned subsidiary of Wako Pure Chemical Industries, Ltd. of Japan. Wako Pure Chemicals Industries, Ltd., worldly renowned for its high purity chemicals, established...

Pure Via

Pure Via® is an all-natural, zero-calorie sweetener this is made from Rebaudioside A (Reb A), the sweetest, best-tasting part of the stevia leaf. Reb A is generally recognized ...

Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited, established in 2005 after the joint share transfer of two leading century-old Japanese pharmaceutical companies, is continuously generating innovative drugs that e...

DAIICHI SANKYO EUROPE GmbH and SHARE

DAIICHI SANKYO is a global pharmaceutical company that focuses on researching and marketing innovative medications. The company was created in 2005 through the merger of two traditional Japanese e...

More Information about "Daiichi Pure Chemicals Company Limited" on BioPortfolio

We have published hundreds of Daiichi Pure Chemicals Company Limited news stories on BioPortfolio along with dozens of Daiichi Pure Chemicals Company Limited Clinical Trials and PubMed Articles about Daiichi Pure Chemicals Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Daiichi Pure Chemicals Company Limited Companies in our database. You can also find out about relevant Daiichi Pure Chemicals Company Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record